SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (447)5/29/2007 5:08:05 PM
From: tuck   of 523
 
>>Neurogen files $100 mln universal shelf
By Gabriel Madway
Last Update: 4:49 PM ET May 29, 2007

SAN FRANCISCO (MarketWatch) -- Neurogen Corp. (NRGN : 7.61, -0.12, -1.6% ) said late Tuesday it has filed a $100 million universal shelf registration statement with the Securities and Exchange Commission, allowing the company to sell debt securities, stock and warrants. Branford, Conn.-based Neurogen, a drug discovery and development company, expects to use the proceeds from any sale for general corporate purposes.<<

Did they use up the last shelf? I haven't looked at burn recently. Sold my position for a modest profit, in the hope of buying it back cheaper this summer. Need to review the potential newsflow. No reaction after hours that I can see.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext